Journal of Pharmacology and Experimental Therapeutics: 251 (1)

October 01, 1989; Volume 251,Issue 1

You have access
The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
S P Welch, A K Singha and W L Dewey

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 1-8;
You have access
Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;
You have access
Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
M A Oriowo, J A Bevan and R D Bevan

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 16-20;
You have access
Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
H N Bhargava, A Gulati and P Ramarao

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 21-26;
You have access
Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
R E Solomon, M J Brody and G F Gebhart

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 27-38;
You have access
Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
A Costard-Jäckle and M R Franz

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 39-46;
You have access
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;
You have access
Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.
Z Z Pan and J T Williams

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 56-62;
You have access
Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
R K Hoover and M L Toews

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 63-70;
You have access
The role of serotonin in the canine secretory response to cholera toxin in vivo.
C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;
You have access
Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
J G Gerber, K S Bedell and A S Nies

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 77-81;
You have access
Ammonium ions cause relaxation of isolated canine arteries.
M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;
You have access
The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
L Mei, J Lai, H I Yamamura and W R Roeske

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;
You have access
Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;
You have access
CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;
You have access
CI-943, a potential antipsychotic agent. II. Neurochemical effects.
T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;
You have access
CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;
You have access
Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;
You have access
Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.
R D Spealman, B K Madras and J Bergman

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 142-149;
You have access
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
J Bergman, B K Madras, S E Johnson and R D Spealman

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;
You have access
Inhibition of rat brain glutamate receptors by philanthotoxin.
D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;
You have access
Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal cord neurons.
M Mhatre and M K Ticku

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 164-168;
You have access
1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;
You have access
Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
R J Lukas

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 175-182;
You have access
Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;
You have access
Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;
You have access
Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase.
D Y Mitchell and D R Petersen

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 193-198;
You have access
Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;
You have access
High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents.
M Klein and J M Musacchio

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 207-215;
You have access
Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
C W Stevens and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 216-223;
You have access
Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;
You have access
Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
D R Kapusta, S Y Jones and G F DiBona

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 230-237;
You have access
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
H Y Meltzer, S Matsubara and J C Lee

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;
You have access
Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
J E Shook, T F Burks, J W Wasley and J A Norman

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;
You have access
Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
Y Satoh, J D Kohli and L I Goldberg

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 253-257;
You have access
Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
S Ofori, R E Heikkila and W J Nicklas

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 258-266;
You have access
Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
M F Piercey and F J Einspahr

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 267-271;
You have access
Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
W J Martin, D L Kachel, T Vilen and V Natarajan

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;
You have access
Effects of adenosine A2 receptor agonists on nucleoside transport.
J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;
You have access
Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
B C Sallustio, Y J Purdie, D J Birkett and P J Meffin

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;
You have access
Renal handling of aspirin in the rat.
F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;
You have access
Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;
You have access
Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;
You have access
Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;
You have access
Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
I A Bakker-Woudenberg, A F Lokerse and F H Roerdink

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 321-327;
You have access
Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
S Marleau, H Ong, A De Léan and P du Souich

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;
You have access
Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.
M J Millan

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 334-341;
You have access
Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
M J Millan, A Członkowski, A Lipkowski and A Herz

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;
You have access
Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;
You have access
Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration.
A Greischel and G Zahn

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 358-361;
You have access
Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;
You have access
Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;
You have access
Developmental changes of the G proteins-muscarinic cholinergic receptor interactions in rat heart.
K K McMahon

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 372-377;
You have access
Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
P W Kalivas, P Duffy and J Barrow

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 378-387;
You have access
A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
J M Paris and S A Lorens

Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 388-393;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals